The ACS National HPV Vaccination Roundtable’s Best Practice Task Group has developed a series of short, easy to read documents that present scientific evidence that address clinical, public health, health system policy, and social-system policy questions related to HPV vaccine acceptance. Each summary includes basic findings from research on “What’s Known,” “What’s New,” and “What’s Next,” on the following topics:
Updated in 2024:
• Epidemiologic Evidence of HPV Vaccine Effectiveness and Safety
• HPV Vaccination at 9-12 Years of Age
• Rural Disparities in HPV Vaccination Coverage
• School Entry Requirements for HPV Vaccination
• Clinical Communication about HPV Vaccination
• Clinical System Approaches to Improving HPV Vaccination
Other Evidence Summaries:
